Andre

🧵(1/9) February 2026, not sure what to say, so let's dive in: Something about these markets is crazy these days, or at least beyond my understanding, but still, this month concluded with a relatively solid performance +9,4% vs. -0.4% S&P 500 (all in €)

Not ideal when you're about to increase your position :/

@cheatgebiet Aber dann würde es doch wieder steigen, oder bin ich zu grenzdebil?

@PerryGlasenberg Krypto stoppt meine Lebensdauer wenn es so weitergeht wie letzten zyklus

TradingView beleidigt einen indirekt als fett und das ist NICHT cool

Can this be a solution?

@HatfieldCapital They also bought back shares before the Teton 2 readout, superb capital allocation

$1.5B ASR at $UTHR. Shrink the float in front of inhaler launch

In the Gulf right now, Chinamaxxing is no joke!

@zipjet @mbamcnulty Do you eventually see AI speeding up such processes in the future?

$LQDA - I do not understand what is taking Andrews so long to decide. In general I tend to defer to the judge to determine how quickly to rule. Long ago there was a judge that I regularly appeared before. He was smart and very careful. But he took way too long to decide cases. He had the lowest reversal rate of any judge in the circuit. When he decided, the cases were well reasoned and carefully supported. But justice delayed is justice denied. He failed on this factor. Ultimately, the Supreme Court removed him for cause. Tough end for a good guy that was in over his head.

$LQDA It’s now getting seriously unprofessional that we still do not have a ruling

$UTHR Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal PAH Study, Delivering Exceptional, Highly Statistically Significant Efficacy businesswire.com/news/home/2026…

⚠️📉 Strait of Hormuz: Data Confirms Near-Total Shutdown. The impact of the Iran War is now visible in the data. On March 1, traffic through the world’s most vital energy artery hit a cliff, dropping 80.8% below the 7-day average. The War Stats (01-03): • Total Crossings: 18 (-65.4% from 28-02). • Flow: 4 Inbound | 14 Outbound. The Fleet Breakdown: • Vessels: 7 Bulk, 3 Oil Tankers, 3 Specialized, 2 Cargo, 1 LPG, 1 Container. • Top Flags: Panama (4), Liberia (3), Marshall Is. (3), Iran (2), Comoros (2). As the Total Crossings line flatlines, the de facto blockade of the Gulf is no longer a threat, it's a reality. Shipping majors have retreated, leaving only 18 vessels to braving the conflict zone.

@TheNarrenschiff @HatfieldCapital @BDC_Analyst You're not wrong with this assessment of the whole situation, though no words are required to see which side is more spiteful

@HatfieldCapital @BDC_Analyst I don't know anything about this company, but I have seen some people post on here about $LQDA. Am I witnessing a big feelings disagreement between two fan bases here?

There is no way this isn't a parody account.

@stock_logging Thanks for the detailed logging, it gives some interesting ideas to think about

Portfolio Update February 2026 📊 Performance 02/2026 (measured as TTWROR in EUR): +4.22% 📊 Performance YTD 2026 (measured as TTWROR in EUR):+6.66 % ➡️ Holdings: $ELS.AX $HROW $URGN $247A.T $5314.TW $SLYG $NURS.V $SOFW.TA $196A.T $MLUAV.PA $277A.T $ALLIX.PA $undisclosed European smallcap $NRXS $YB $4419.T $3496.T $PRPO $462A.T $2181.HK $FIN.L 📢 Monthly Commentary → Markets remained highly volatile in February. Software stocks in particular were hit hard, as the market was increasingly pricing in broad disruption risk from vibecoded software and the potential displacement of blue-collar workers (which would negatively impact the often seat-based revenue models). → The situation was further amplified by the viral Citrini paper, which painted a gloomy picture of an AI-dominated economy with many structural losers. In my view, it was a highly interesting read, but IMO too alarmist in its conclusions. → I used the sell-off in software, consulting, and platform stocks to initiate and add to several positions in Japan. Japanese small-cap growth names were sold off almost indiscriminately in February, often despite solid quarterly results. This happened while the Nikkei and various Japanese data center niche leaders are trading near all-time highs. → IMO, the market is acting irrationally here, which I have taken advantage of. I believe it is only a matter of time before Japanese small-cap growth stocks are rediscovered. Companies delivering sustainable earnings growth well above 30% should not trade below 20x earnings for long, in my view. → To what extent today’s escalation in the Middle East will weigh on markets in March remains to be seen. I sincerely hope a peaceful resolution can be found quickly. Either way, the overall market environment remains challenging. → So far, I have largely avoided the extremely negative post-earnings reactions we have seen across many names. However, several important quarterly reports for my portfolio are still ahead in March, with $URGN and $HROW both on Monday being particularly decisive for my performance. → My portfolio held up relatively well in February compared to the broader market and finished the month up more than 4%. A significant portion of the performance was once again driven by $ELS.AX, while $HROW also contributed meaningfully following very bullish January and February Vevye sales data. → I am, however, quite dissatisfied (even though it is obviously outside my control) with the weak start to the year for $NURS.V. I slightly reduced my position mid-month after the FDA (following the highly questionable GLP-1 advertising by $HIMS) signaled that it may move to effectively ban compounded GLP-1 products altogether. With an estimated 40% of revenue coming from GLP1 in the VSDHOne segment, such a decision would represent a significant blow to NURS. I therefore adjusted the position size to reflect this regulatory risk. ➕ New positions ▪️ $196A.T $3496.T $4419.T 🔼 Increased positions ▪️ $URGN $PRPO $5314.TW $277A.T $247A.T $462A.T ❌ Exited positions ▪ $HIT $0236.KL $4493.T $241A.T 🔻 Trimmed positions ▪️ $NURS.V ⬆️️ Top performers 02/26: ▪️ $276A.T CCReB: +57.87% (position closed on Feb 05, 2026) ▪️ $NRXS: +43.21% ▪️ $HROW: +33.62% ▪️ $MLUAV.PA: +25.00% ▪️ $462A.T Fundinno:+18.23% ⬇️ Underperformers 02/26: ▪️ $2181.HK: -19.76% ▪️ $NURS.V: -13.58% ▪️ $SLYG.DE: -13.16% ▪️ $ALLIX.PA: -12.80% ▪️ $196A.T MFS Inc.: -10.71% (position opened on Feb 17, 2026)

🧵(9/9) My goal remains to generate a high outperformance with moderate risk and to use some concentration to achieve this, but some more diversification is required

🧵(8/9) Therefore I started taking some measures like including an ETF and opening a new position in Simplex Holdings, which is a 🇯🇵 technology/software company in the finance sector that was massively sold off due to AI, which I find a bit overblown

🧵(1/9) February 2026, not sure what to say, so let's dive in: Something about these markets is crazy these days, or at least beyond my understanding, but still, this month concluded with a relatively solid performance +9,4% vs. -0.4% S&P 500 (all in €)